NCT04969900

Brief Summary

The investigators propose a single-site, double-blinded, placebo-controlled clinical trial of lavender aromatherapy versus placebo for patient satisfaction in adult women having a surgical abortion before 10 weeks and 0 days gestation. The investigators will evaluate whether lavender aromatherapy is an effective adjunct therapy for patient satisfaction during first trimester surgical abortion. The investigators will measure satisfaction using the Iowa Satisfaction with Anesthesia Scale (ISAS). The investigators hypothesize that women receiving lavender aromatherapy will report higher satisfaction scores compared to women receiving placebo. Prior studies have investigated the use of aromatherapy in laboring patients, in menstruating women, and in general post-operative populations. No investigations have focused on the use of lavender aromatherapy as an adjunct therapy to paracervical block and/or oral narcotics and anxiolytics in outpatient surgical abortion. Our study is novel in investigating patient satisfaction with first trimester surgical abortion using lavender aromatherapy. The contribution of this proposed research to the literature is significant because current affordable anesthetic adjuncts to opioids and benzodiazepines are limited.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 13, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 25, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

July 21, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2022

Completed
3.3 years until next milestone

Results Posted

Study results publicly available

August 3, 2025

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

12 months

First QC Date

June 25, 2021

Results QC Date

April 6, 2023

Last Update Submit

July 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient Satisfaction With Anesthesia

    Difference in patient satisfaction with their abortion experience as measured on the Iowa Satisfaction with Anesthesia Scale (ISAS) following a surgical abortion less than 10 weeks 0 days gestational age between women randomized to lavender aromatherapy versus placebo. The self-reported questionnaire consists of 11 items such as "I hurt," "I felt safe," "I had nausea," each assessed on a Likert-type scale ranging from "Disagree very much" to "Agree very much." The responses are then scored from -3 (least satisfied) to +3 (most satisfied) and an average composite score is obtained.

    15 minutes post-procedure

Secondary Outcomes (3)

  • Maximum Procedural Pain

    Immediately post-procedure

  • Acceptability

    11 months

  • Patient Acceptability of Lavender Aromatherapy in Procedural Abortion

    15 minutes post-procedure

Study Arms (2)

Placebo - Jojoba Oil (100% organic golden expeller-pressed Simmondsia chinensis)

PLACEBO COMPARATOR

Study randomization to lavender aromatherapy or placebo will occur just prior to the initiation of the abortion procedure. A permutated block stratified randomization scheme will be utilized so that equal numbers of participants receiving no sedation and PO sedation will be randomized to lavender aromatherapy or placebo. 1cc of dilute lavender aromatherapy and placebo will be pre-filled in a 5/8 dram mini amber glass bottle provided to the patient. Immediately prior to procedure start (defined as after receiving antibiotic and emptying bladder), participants will be instructed to self-administer the study product. They will bring down their personal cloth mask to chin level and rub the study product within the amber glass bottle on their upper lip and nose (left and right ala, alarfacial grooves, and columella). Participants will be instructed to take 4 deep breaths and then replace their mask over their nose. The patient will then proceed to the procedure.

Other: Placebo oil

Investigational Product - A 10% dilute Lavandula angustifolia - jojoba oil essential oil blend

ACTIVE COMPARATOR

Study randomization to lavender aromatherapy or placebo will occur just prior to the initiation of the abortion procedure. A permutated block stratified randomization scheme will be utilized so that equal numbers of participants receiving no sedation and PO sedation will be randomized to lavender aromatherapy or placebo. 1cc of dilute lavender aromatherapy and placebo will be pre-filled in a 5/8 dram mini amber glass bottle provided to the patient. Immediately prior to procedure start (defined as after receiving antibiotic and emptying bladder), participants will be instructed to self-administer the study product. They will bring down their personal cloth mask to chin level and rub the study product within the amber glass bottle on their upper lip and nose (left and right ala, alarfacial grooves, and columella). Participants will be instructed to take 4 deep breaths and then replace their mask over their nose. The patient will then proceed to the procedure.

Other: Lavender oil.

Interventions

The placebo group will receive placebo oil.

Placebo - Jojoba Oil (100% organic golden expeller-pressed Simmondsia chinensis)

Investigational Product. This group will receive Lavender oil.

Investigational Product - A 10% dilute Lavandula angustifolia - jojoba oil essential oil blend

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsEnrollment is limited to patients undergoing a pregnancy termination; therefore, all subjects must be female.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women18 years or older
  • Have decide to have a pregnancy termination with no sedation or oral sedation.
  • Are less than10 weeks 0 days gestational age with viable pregnancy.
  • Agree to being randomized to aromatherapy or placebo

You may not qualify if:

  • Contraindications or allergies to ibuprofen, lidocaine, or jojoba oil.
  • A non-viable intrauterine pregnancy
  • A pregnancy greater than or equal to 10 weeks gestational age.
  • Adults who are unable to consent or who are currently incarcerated.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Comprehensive Women's Health Center

Denver, Colorado, 80230, United States

Location

Related Publications (1)

  • Free LL, Sheeder J, Cohen RH. Effects of aromatherapy on patient satisfaction with procedural abortion at less than 10 weeks' gestation: A randomized controlled trial. Contraception. 2024 Feb;130:110311. doi: 10.1016/j.contraception.2023.110311. Epub 2023 Oct 17.

Related Links

MeSH Terms

Conditions

Patient SatisfactionPain

Interventions

lavender oil

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Leanne Free
Organization
Principal Investigator

Study Officials

  • Leanne Free, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
For purposes of masking, all patients enrolled in the study will be required to wear a cloth face covering over their nose and mouth during their procedure to minimize diffusion of the aromatic scent in the procedure room.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A single-site, double-blinded, placebo-controlled clinical trial of lavender aromatherapy versus inert oil placebo for patient satisfaction in adult women having a first trimester outpatient surgical abortion before 10 weeks and 0 days gestation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2021

First Posted

July 21, 2021

Study Start

May 13, 2021

Primary Completion

April 26, 2022

Study Completion

April 26, 2022

Last Updated

August 3, 2025

Results First Posted

August 3, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations